- supports and increases the rate of metabolism
- helps combat the symptoms and causes of stress, depression, and cardiovascular disease.
- helps to maintain healthy skin and muscle tone
- enhances immune and nervous system function
- plays an important role in cell metabolism
- B3 helps to prevent mental confusion, assists in the production of steroid hormones made by the adrenal gland, and removes toxic chemicals from the body
- B6 helps prevent depression (it is required for the production of the neurotransmitters serotonin, dopamine, noradrenaline and adrenaline), high blood pressure, and water retention.
- B9 slows aging of the brain, is necessary for the production and maintenance of new cells, eleviates depression.
- B12 improves memory and other cognitive functions
For more information on each of the ingredients in the DRIVE™ formula, please click on the links below:
Taurine | Rhodiola Rosea | Caffeine |
Vinpocetine | B-Vitamins
|
Scientific Research Supporting B-Vitamins:
- Victor Herbert (1988). "Vitamin B-12: plant sources, requirements, and assay
- Jane Higdon, "Niacin", Micronutrient Information Center, Linus Pauling Institute
- Katzung, Basic and Clinical Pharmacology, 9th ed. p. 570
- NIH Medline Plus: Niacin. http://www.nlm.nih.gov/medlineplus/ency/article/002409.htm
- Kamen B (1997). "Folate and antifolate pharmacology". Seminars in oncology 24 (5 Suppl 18): S18-30-S18-39
- Coppen A, Bolander-Gouaille C. (2005). "Treatment of depression: time to consider folic acid and vitamin B12". Journal of Psychopharmacology 19 (1): 59-65.
- Taylor MJ, Carney SM, Goodwin GM, Geddes JR. (2004). "Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials". Journal of Psychopharmacology 18 (2): 251-6
- "ScientistLive Website". American Journal of Epidemiology.
- Dr Jane Durga, Martin PJ van Boxtel, Prof Evert G Schouten, Prof Frans J Kok, Prof Jelle Jolles, Martijn B Katan, and Petra Verhoef Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial The Lancet 2007; 369:208-216
- Council of Experts. USP/NF. 2006 Ed. Rockville, MD: The United States Pharmacopeial Convention; 2005
|